Filament Health gets new US patent in natural psilocybin estate
Rhelion Life Sciences’ wholly owned subsidiary Filament Health issued a new United States patent, extending its natural psilocybin patent estate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Rhelion Life Sciences’ wholly owned subsidiary Filament Health issued a new United States patent, extending its natural psilocybin patent estate.